It was also observed to significantly reduce the expressions of cyclin D1 and cyclin E, together with CDK4 and CDK2 in the ovarian cancer cells (anti-ovarian) (Yin et al., 2023). The gene discussed is CDK2; the disease is ovarian carcinoma.